Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-Rong Li

Showing results (301-310 of 309) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 309 results.
Infectious Agents and Cancer|May 1, 2024
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective studyDa-Long Yang, Shao-Ping Liu, Hong-Liang Wang, et al.
NPJ Precision Oncology|October 5, 2024
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancerChenyang Li, Thinh T Nguyen, Jian-Rong Li, et al.
Nature Materials|June 18, 2026
Methane storage using metal-dipyrazolate frameworksXiang-Jing Kong, Varvara I Nikolayenko, Alan C Eaby, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 8, 2016
The prognostic value of plasma nesfatin-1 concentrations in patients with traumatic brain injuryGang-Qun Wu, Xiao-Min Chou, Wen-Jian Ji, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation StudyJia-Yong Su, De-Jia Huang, Shao-Ping Liu, et al.
Liver Cancer|August 20, 2025
Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort StudyJia-Yong Su, Shao-Ping Liu, Xiao-Ling Xu, et al.
Nature Communications|August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cellsLisa Brunet, David Alexandre, Jiyoung Lee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 25, 2026
Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen ExposureBo Zhu, Muhammad Aminu, Pingjun Chen, et al.
Cancer Cell|May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interceptionBo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Pageof 31

Showing results (301-310 of 309) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 309 results.
Infectious Agents and Cancer|May 1, 2024
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective studyDa-Long Yang, Shao-Ping Liu, Hong-Liang Wang, et al.
NPJ Precision Oncology|October 5, 2024
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancerChenyang Li, Thinh T Nguyen, Jian-Rong Li, et al.
Nature Materials|June 18, 2026
Methane storage using metal-dipyrazolate frameworksXiang-Jing Kong, Varvara I Nikolayenko, Alan C Eaby, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 8, 2016
The prognostic value of plasma nesfatin-1 concentrations in patients with traumatic brain injuryGang-Qun Wu, Xiao-Min Chou, Wen-Jian Ji, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation StudyJia-Yong Su, De-Jia Huang, Shao-Ping Liu, et al.
Liver Cancer|August 20, 2025
Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort StudyJia-Yong Su, Shao-Ping Liu, Xiao-Ling Xu, et al.
Nature Communications|August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cellsLisa Brunet, David Alexandre, Jiyoung Lee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 25, 2026
Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen ExposureBo Zhu, Muhammad Aminu, Pingjun Chen, et al.
Cancer Cell|May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interceptionBo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Pageof 31